Meningioma – Diagnostics

Go back

Understanding how meningioma is diagnosed can make the journey less overwhelming. From recognizing early warning signs to navigating advanced imaging tests and meeting with specialists, knowing what to expect at each step helps patients and families feel more prepared and confident in making decisions about their care.

Who Should Seek Diagnostic Testing

Meningioma often grows very slowly over many years, which means it may not cause any noticeable problems for a long time. Because of this gradual growth pattern, many people don’t realize they have a meningioma until it becomes larger or is discovered accidentally during tests ordered for completely different reasons. For instance, someone who has a head scan after a minor accident might learn they have a meningioma that was quietly growing without causing any symptoms at all.[1]

If you begin experiencing certain symptoms, it’s important to seek medical attention. These symptoms can include headaches that seem worse in the morning, changes in your vision such as seeing double or experiencing blurriness, hearing loss or ringing in the ears, memory problems, loss of smell, seizures, or weakness in your arms or legs. Some people may also notice difficulty speaking or changes in their ability to move normally.[1][2]

The symptoms you experience often depend on where exactly the meningioma is located in your brain or, in rare cases, along your spinal cord. A tumor growing in one area might affect your vision, while one in another location could impact your sense of smell or cause weakness in one of your legs. This is because the tumor presses against different parts of the brain or nerves, interfering with their normal function.[3]

⚠️ Important
Meningiomas can be difficult to diagnose because they grow slowly and their symptoms may resemble normal signs of aging, especially in adults over age 65. If you have concerns about any symptoms, don’t hesitate to seek a second opinion if your first doctor doesn’t take them seriously.

It’s worth noting that meningiomas are more common in certain groups of people. Women are diagnosed more frequently than men, and the risk increases as you get older, particularly after age 60. People who are Black, those who have undergone radiation therapy to the head (especially during childhood), individuals using hormone replacement therapy or birth control pills, and those with a family history of meningiomas or certain genetic conditions may be at higher risk.[2][4]

Because meningiomas can grow quite large before causing noticeable problems, and because some smaller tumors may never need treatment at all, seeking diagnostic testing when you notice unusual or persistent symptoms is the best approach. Early detection allows doctors to monitor the tumor’s growth and plan appropriate care if needed.[1]

Standard Diagnostic Methods

When you first visit a doctor with concerns about possible meningioma symptoms, the diagnostic process typically begins with a thorough physical examination and a detailed neurological exam, which is a specialized examination that tests how well your brain and nervous system are functioning. During this exam, the doctor will check your balance, coordination, reflexes, muscle strength, and sensory responses. They may ask you to walk down a hallway, follow their finger with your eyes, or perform other simple tasks that reveal how different parts of your nervous system are working.[8][9]

The neurological exam is important because it can identify subtle problems that might not be obvious in everyday activities. For example, a doctor might notice slight balance issues or coordination problems that you’ve learned to compensate for without realizing it. This kind of careful observation helps determine whether brain imaging is necessary and what areas of the brain need closer examination.[8]

If the neurological exam raises concerns or if your symptoms suggest a possible brain tumor, the next step is imaging tests. These are the primary tools used to actually see the meningioma and understand its size, location, and characteristics. The two main imaging tests used for diagnosing meningiomas are MRI scans (magnetic resonance imaging) and CT scans (computed tomography).[8][9]

An MRI scan is considered the gold standard for diagnosing meningiomas. This test uses powerful magnets and radio waves to create detailed, cross-sectional images of your brain. Unlike X-rays, MRI doesn’t use radiation. Instead, it takes advantage of how water molecules in your body respond to magnetic fields. The test is painless, though you do need to lie still inside a tunnel-like machine for 30 to 60 minutes, which some people find uncomfortable or anxiety-provoking. The machine makes loud thumping and buzzing noises, so you’ll usually be given earplugs or headphones.[8]

During the MRI, you’ll typically receive a contrast dye, which is a special liquid injected into your vein that makes the meningioma easier to see on the images. This dye, often containing a substance called gadolinium, highlights the tumor by making it appear brighter than surrounding brain tissue. Meningiomas usually show up as bright, well-defined masses on the outer surface of the brain when contrast is used. The MRI provides such detailed pictures that doctors can often tell the difference between a meningioma and other types of brain tumors just by looking at the images.[8]

A CT scan is an alternative imaging method that uses X-rays to create cross-sectional images of your brain. The CT scanner rotates around your head, taking pictures from many angles, and a computer combines these to create detailed slices showing the inside of your skull. CT scans are faster than MRI—usually taking just 10 to 20 minutes—and can be helpful when someone can’t have an MRI (for example, if they have certain metal implants or are very claustrophobic). Like MRI, CT scans often use a contrast dye, typically containing iodine, to make the tumor more visible.[8][9]

In most cases, imaging alone is enough to diagnose a meningioma and distinguish it from other types of brain tumors. However, sometimes a biopsy is needed to confirm the diagnosis and determine the exact grade of the tumor. A biopsy involves removing a small sample of tumor tissue, which is then examined under a microscope by a specialist called a neuropathologist. This examination reveals the tumor’s characteristics and helps classify it into one of three grades.[4][8]

Grade 1 meningiomas are the most common, representing about 80-90% of all cases. These are slow-growing and considered benign, meaning they’re not cancerous. Grade 2 meningiomas are called atypical and grow somewhat faster with a higher chance of coming back after treatment. Grade 3 meningiomas are called anaplastic or malignant and are the rarest, representing about 1-3% of cases. These grow quickly and are considered cancerous.[4][5]

In many cases, the biopsy is performed during surgery to remove the tumor rather than as a separate procedure beforehand. If the tumor is in a difficult-to-reach location or surgery isn’t planned, doctors might use the imaging findings to estimate the tumor grade and plan treatment accordingly. The grade determined by the neuropathologist is based on examining the tumor cells themselves, looking at factors like how actively they’re dividing and whether the cells appear abnormal.[4]

Diagnostic Testing for Clinical Trial Enrollment

Clinical trials are research studies that test new treatments or approaches to managing meningiomas. If you’re considering participating in a clinical trial, you’ll need to undergo specific diagnostic tests to determine whether you’re eligible. These tests serve two important purposes: they ensure you’re a good candidate for the particular treatment being studied, and they provide baseline measurements that researchers can use to track how well the treatment works over time.[11]

The specific tests required vary depending on the clinical trial, but most trials use imaging scans as a standard requirement. MRI or CT scans are typically performed to document the exact size and location of your meningioma before treatment begins. These baseline images are crucial because researchers need to compare them with images taken during and after treatment to measure whether the tumor has shrunk, stayed the same size, or grown. The images must usually be recent—often within a few weeks of starting the trial—to provide an accurate starting point.[4]

Many clinical trials also require confirmation of the tumor grade through tissue analysis. If you’ve already had surgery to remove part or all of your meningioma, the tissue samples from that procedure may be used. A neuropathologist will review the tissue to confirm you have the specific type and grade of meningioma that the trial is designed to treat. Some trials focus exclusively on higher-grade meningiomas (grades 2 or 3), while others may include all grades, so this confirmation is essential for enrollment.[4]

Blood tests are commonly required as well. These tests check your overall health and organ function to ensure you can safely receive the treatment being studied. For instance, researchers might check your kidney function, liver function, and blood cell counts. These baseline measurements help identify any pre-existing problems that might make the experimental treatment unsafe for you, and they also provide comparison points if side effects occur during the trial.[5]

Some clinical trials investigating targeted treatments or new drug therapies may require additional specialized testing. For example, researchers might look for specific genetic changes or biomarkers (measurable biological indicators) in your tumor tissue. These tests can reveal whether your tumor has certain characteristics that make it more likely to respond to the treatment being studied. This approach, called personalized or precision medicine, helps match patients to treatments that are most likely to help them.[11]

Throughout the clinical trial, you’ll typically undergo repeated imaging scans at scheduled intervals—perhaps every few months. These follow-up scans allow researchers to monitor how your meningioma responds to treatment. The frequency and type of imaging depend on the trial protocol, which is the detailed plan describing exactly how the study will be conducted. Some trials may also include additional tests to monitor for specific side effects associated with the treatment being studied.[11]

⚠️ Important
Clinical trial eligibility criteria can be quite specific. Don’t be discouraged if you don’t qualify for one trial—there may be others that are a better fit for your particular situation. Your medical team can help you understand which trials might be appropriate and what diagnostic tests would be needed.

It’s important to understand that participating in a clinical trial may involve more frequent medical visits and additional testing compared to standard care. However, this close monitoring also means your condition is being watched very carefully, and you’ll have regular contact with a team of specialists who are experts in meningioma treatment. Before enrolling, you’ll receive detailed information about all the tests and procedures involved, and you can ask questions to help you decide whether participation is right for you.[11]

Prognosis and Survival Rate

Prognosis

The outlook for people with meningiomas varies considerably depending on several key factors. The tumor’s grade is one of the most important considerations. Grade 1 meningiomas, which make up the vast majority of cases, typically have an excellent prognosis. These slow-growing tumors often respond very well to treatment, with many patients achieving complete removal through surgery and experiencing no recurrence for many years or even decades.[4][7]

Grade 2 atypical meningiomas have a somewhat less favorable outlook because they grow more quickly and have a higher chance of returning after treatment. These tumors may require more aggressive treatment approaches, including surgery followed by radiation therapy, and closer long-term monitoring. Grade 3 anaplastic meningiomas have the most challenging prognosis. These rare, fast-growing tumors are more likely to invade surrounding brain tissue and may even spread to other parts of the body, though this is uncommon.[4][5]

The tumor’s location significantly affects prognosis as well. Meningiomas on the outer surface of the brain are often easier to remove completely than those at the base of the skull or those that involve critical blood vessels or nerves. A tumor wrapped around important structures may not be fully removable without causing serious complications, which can affect long-term outcomes. Additionally, larger tumors or those that have caused significant symptoms before diagnosis may have a more complex recovery process.[3]

Age and overall health also play important roles. Younger, healthier patients generally tolerate treatment better and may have better outcomes. However, many meningiomas grow so slowly that even older patients can live comfortably for many years with appropriate management, whether that involves surgery, radiation, or careful monitoring without immediate intervention.[1][8]

Survival Rate

Overall, meningiomas have high survival rates, particularly for Grade 1 tumors. Eight out of ten cases of meningiomas respond well to treatment and can be considered cured, meaning the tumor is successfully removed and doesn’t return.[6]

For higher-grade meningiomas, survival rates are more variable. Grade 3 anaplastic meningiomas have a five-year survival rate ranging from 32 to 64 percent, which reflects the more aggressive nature of these tumors and their tendency to recur even after treatment.[5]

It’s important to understand that survival statistics are based on large groups of people and may not accurately predict any individual person’s outcome. Many factors unique to each patient—including the specific characteristics of their tumor, their response to treatment, and advances in medical care—can significantly influence their personal prognosis. Some people with meningiomas live many years without significant problems, while others may require ongoing treatment and monitoring.[4]

For many patients with slow-growing Grade 1 meningiomas, especially those that are small and not causing symptoms, the prognosis is excellent. Some of these tumors may never require treatment at all and can be managed with regular imaging to monitor for any changes. This “watch and wait” approach allows many people to maintain their quality of life without undergoing surgery or other treatments unless absolutely necessary.[8]

Ongoing Clinical Trials on Meningioma

  • Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options

    Recruiting

    1 1 1
    Investigated diseases:
    Austria Denmark France Germany Italy The Netherlands +2

References

https://www.mayoclinic.org/diseases-conditions/meningioma/symptoms-causes/syc-20355643

https://my.clevelandclinic.org/health/diseases/17858-meningioma

https://www.brighamandwomens.org/neurosurgery/meningioma

https://www.cancer.gov/rare-brain-spine-tumor/tumors/meningioma

https://www.ncbi.nlm.nih.gov/books/NBK560538/

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/meningioma

https://www.abta.org/tumor_types/meningioma/

https://www.mayoclinic.org/diseases-conditions/meningioma/diagnosis-treatment/drc-20355648

https://my.clevelandclinic.org/health/diseases/17858-meningioma

https://pmc.ncbi.nlm.nih.gov/articles/PMC10526192/

FAQ

Can a meningioma be diagnosed without a biopsy?

Yes, in most cases meningiomas can be diagnosed based on MRI or CT imaging alone, without needing a biopsy. The characteristic appearance of meningiomas on these scans, particularly with contrast dye, allows experienced doctors to identify them with high confidence. A biopsy is typically only needed when imaging results are unclear or when doctors need to confirm the exact grade of the tumor for treatment planning.

How long does it take to get a meningioma diagnosis after symptoms start?

The time from symptom onset to diagnosis varies widely because meningiomas grow slowly and their symptoms can be subtle or mistaken for other conditions. Some people experience symptoms for several months before seeking medical attention or receiving proper testing. In other cases, diagnosis happens quickly if symptoms are severe or if a doctor orders brain imaging early in the evaluation process. Unfortunately, symptoms are sometimes initially dismissed as normal aging or stress, which can delay diagnosis.

What’s the difference between a CT scan and an MRI for diagnosing meningioma?

Both CT and MRI scans can detect meningiomas, but MRI is generally preferred because it provides more detailed images of soft tissues like the brain and can better show the tumor’s relationship to surrounding structures. MRI uses magnetic fields and radio waves, while CT uses X-rays. CT scans are faster and may be used when someone cannot have an MRI due to metal implants or severe claustrophobia. Both tests typically use contrast dye to make the tumor more visible.

If my meningioma is discovered incidentally, do I need treatment right away?

Not necessarily. Many meningiomas found by accident are small and not causing any symptoms. In these cases, doctors often recommend a “watch and wait” approach with regular imaging to monitor the tumor over time. Treatment is typically only needed if the tumor grows, begins causing symptoms, or is in a location where growth could become dangerous. Your doctor will help you understand whether immediate treatment or monitoring is best for your specific situation.

What should I bring to my first appointment with a neurologist?

Bring a list of all your symptoms, when they started, and how they’ve changed over time. Include information about your medical history, medications, and any previous imaging scans or test results. If you’ve had MRI or CT scans at another facility, request copies of the images (usually provided on a CD or USB drive) and the radiologist’s report. A list of questions you want to ask is also helpful, as appointments can feel overwhelming and it’s easy to forget what you wanted to discuss.

🎯 Key Takeaways

  • Meningiomas often cause no symptoms for years and are frequently discovered accidentally during brain scans ordered for other reasons.
  • MRI with contrast dye is the gold standard for diagnosing meningiomas, providing detailed images that can usually identify the tumor without needing a biopsy.
  • A thorough neurological exam can reveal subtle balance or coordination problems that you might have learned to compensate for without realizing.
  • Grade 1 meningiomas represent 80-90% of cases and have excellent treatment outcomes, with many patients considered cured after surgery.
  • Symptoms vary dramatically based on tumor location—a meningioma pressing on your optic nerve causes different problems than one affecting your sense of smell.
  • Clinical trials for meningioma require specific diagnostic tests including recent imaging and often tissue analysis to confirm tumor grade and eligibility.
  • Not all meningiomas need immediate treatment—many slow-growing tumors are safely monitored with regular imaging rather than requiring surgery right away.
  • If your doctor dismisses your symptoms, seeking a second opinion is important, as meningioma symptoms can easily be mistaken for normal aging.